To identify the subpopulation of putative CSCs in cancer cell lines, we investigated the expression of three stem cell surface markers (CD166, CD44, and EpCAM) that previously were described as prominent CSCs markers in lung cancer. This evidence concerns the gene ALCAM and cancer.